Meningococcal Vaccines Offers Excellent Defence Against Four Meningococcal Bacterial Types
Meningococcal Vaccines |
Meningococcal Vaccines are a type of immunization used to
protect against meningococcal disease. This disease is caused by the bacteria
Neisseria meningitidis, which can cause severe infections in the lining of the
brain and spinal cord, as well as bloodstream infections. Meningococcal disease
can be fatal or cause long-term complications, such as brain damage, hearing
loss, and limb amputations.
There are several types of Meningococcal
Vaccines available,
including conjugate vaccines, polysaccharide vaccines, and combination
vaccines. Conjugate vaccines are the most commonly used type and provide
protection against four strains of the bacteria: A, C, W, and Y. Polysaccharide
vaccines provide protection against the same strains but are less effective and
are typically only recommended for people over the age of 55. Combination
vaccines provide protection against meningococcal disease as well as other
diseases, such as diphtheria, tetanus, and pertussis.
According To Coherent
Market Insights, The Global Meningococcal Vaccines Market Is Estimated To
Account For US$ 3,341.9 Mn In Terms Of Value And Is Expected To Reach US$
7,732.3 Mn By The End Of 2027.
Meningococcal Vaccines are typically given in two doses,
with the second dose administered several months after the first. Booster doses
may also be recommended for certain populations, such as people who are
traveling to areas where meningococcal disease is more common or people with
weakened immune systems.
The timing of vaccination is important for ensuring adequate
protection against meningococcal disease. Adolescents and young adults are at
an increased risk for Meningococcal
Disease, with most cases occurring in people between the ages of 15 and 24.
As a result, the Centers for Disease Control and Prevention (CDC) recommends
routine vaccination for adolescents starting at age 11-12, with a booster dose
at age 16. College students, particularly those living in dormitories, are also
at an increased risk for meningococcal disease and should receive the Vaccines.
Comments
Post a Comment